A first hint suggesting a possible link between IL-6 and the eGC came from Ikonomidis et al. who observed a decrease of the PBR (i.e. improvement of the eGC) upon tocilizumab administration in patients with rheumatoid arthritis [34]. Here, IL6 is linked to rheumatoid arthritis.